GROWTH STOCK ANALYZER Open the app
Growth Stock Analyzer › HROW growth analysis
Growth stock analysis · updated 2026-07-28

Harrow, Inc. Common Stock (HROW) growth stock analysis

Is Harrow, Inc. Common Stock a growth stock? A data-driven read on its earnings momentum, price leadership, and demand, scored against every US stock from SEC filings and daily prices, and re-ranked after every close.

Not right now by CANSLIM
18
Growth score
39
RS rating
#4,044
Rank
0/6
Traits passed
18/99
Growth score · 4044th of 4,892 US stocks
CANSLI
Six growth traits, scored 1–99

What the data says about HROW

As of the 2026-07-28 close, HROW scores 18 out of 99 on our growth-stock rating, a weak growth-stock profile. That ranks it 4044th of 4,892 rated US stocks, the top 83% of the market.

Its strongest trait is S (supply & demand) at 48, and its weakest is A (annual earnings growth) at 0. HROW clears 0 of the six core growth traits we score per stock; the seventh, overall market direction, is judged market-wide.

On price, HROW carries a lagging Relative Strength rating of 39, meaning it has outperformed about 39% of the market over the past year.

Underneath the score: sales down 8%, trading 28% below its 52-week high.

HROW growth-trait breakdown

The six traits that separate real growth stocks from the rest: earnings, price leadership, and demand. Each is scored 1–99 against the whole US market. We compute them with the CANSLIM method, double-weighting earnings and relative strength.

C
Current quarterly earnings
most recent EPS growth vs. a year ago
40
A
Annual earnings growth
multi-year earnings trend
0
N
New highs & catalysts
proximity to new 52-week highs
3
S
Supply & demand
volume behind the move vs. share supply
48
L
Leader or laggard
Relative Strength within its group
38
I
Institutional sponsorship
fund accumulation and 13F ownership
29

Is HROW a growth stock?

Not right now by CANSLIM

On today’s data HROW does not clear the growth-stock bar CANSLIM sets. Scores are re-computed after every close, so this can change.

🔒 Stronger growth stocks than HROW

The stocks ranking above HROW today, the growth leaders you’d weigh against it.

See today’s top ranks for free →

🔒 HROW price history & buy range

Where HROW sits in its base, its 52-week path, and the trait trend over the past year.

Open the full HROW profile →

See where HROW ranks among every US growth stock

Every US stock scored on the traits that define a growth stock and re-ranked after each close, with the top ranks, the full trait breakdown, and today’s market read.

Open the app, free through September 1

HROW as a growth stock, frequently asked

Is HROW a good growth stock?

Not right now by CANSLIM. On today’s data HROW does not clear the growth-stock bar CANSLIM sets. Scores are re-computed after every close, so this can change.

What is HROW's growth score?

Harrow, Inc. Common Stock (HROW) scores 18 out of 99 on our growth-stock rating as of the 2026-07-28 close, ranking 4044th of 4,892 rated US stocks.

Does HROW have strong earnings growth?

We don't have current earnings-growth figures for HROW.

How strong is HROW's price performance?

HROW has a Relative Strength rating of 39, meaning it has outperformed roughly 39% of the US market over the trailing year.

Where can I see HROW's full analysis?

Create a free Growth Stock Analyzer account to see where HROW ranks against every US stock, the stronger growth stocks to weigh against it, and its full price and earnings history.

Want the method behind the score? Read how we grade growth stocks with CANSLIM.

More growth stocks in Pharmaceutical Preparations